420 related articles for article (PubMed ID: 16929560)
1. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
[TBL] [Abstract][Full Text] [Related]
2. Determination of platinum originating from carboplatin in canine sebum and cerumen by inductively coupled plasma mass spectrometry.
Janssens T; Brouwers EE; de Vos JP; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2011 Jan; 54(2):395-400. PubMed ID: 20933356
[TBL] [Abstract][Full Text] [Related]
3. Determination of ruthenium originating from the investigational anti-cancer drug NAMI-A in human plasma ultrafiltrate, plasma, and urine by inductively coupled plasma mass spectrometry.
Brouwers EE; Tibben MM; Rosing H; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2007; 21(9):1521-30. PubMed ID: 17410551
[TBL] [Abstract][Full Text] [Related]
4. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
Jacobs SS; Fox E; Dennie C; Morgan LB; McCully CL; Balis FM
Clin Cancer Res; 2005 Feb; 11(4):1669-74. PubMed ID: 15746072
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an inductively coupled plasma mass spectrometry method with optimized microwave-assisted sample digestion for the determination of platinum at ultratrace levels in plasma and ultrafiltrate plasma.
Breda M; Maffini M; Mangia A; Mucchino C; Musci M
J Pharm Biomed Anal; 2008 Sep; 48(2):435-9. PubMed ID: 18508222
[TBL] [Abstract][Full Text] [Related]
6. Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry.
Brouwers EE; Tibben MM; Joerger M; van Tellingen O; Rosing H; Schellens JH; Beijnen JH
Anal Bioanal Chem; 2005 Aug; 382(7):1484-90. PubMed ID: 15952001
[TBL] [Abstract][Full Text] [Related]
7. Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates.
Jacobs S; McCully CL; Murphy RF; Bacher J; Balis FM; Fox E
Cancer Chemother Pharmacol; 2010 Apr; 65(5):817-24. PubMed ID: 19662415
[TBL] [Abstract][Full Text] [Related]
8. Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry.
Zhang W; Seymour L; Chen EX
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):277-82. PubMed ID: 19026601
[TBL] [Abstract][Full Text] [Related]
9. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin.
Xing R; Wang X; Zhang C; Zhang Y; Wang Q; Yang Z; Guo Z
J Inorg Biochem; 2009 Jul; 103(7):1039-44. PubMed ID: 19501911
[TBL] [Abstract][Full Text] [Related]
10. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
Liu J; Kraut E; Bender J; Brooks R; Balcerzak S; Grever M; Stanley H; D'Ambrosio S; Gibson-D'Ambrosio R; Chan KK
Cancer Chemother Pharmacol; 2002 May; 49(5):367-74. PubMed ID: 11976830
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of inductively coupled mass spectrometry for the determination of platinum in plasma.
Allain P; Berre S; Mauras Y; Le Bouil A
Biol Mass Spectrom; 1992 Mar; 21(3):141-3. PubMed ID: 1576172
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic properties of platinium derivatives].
Boisdron-Celle M; Lebouil A; Allain P; Gamelin E
Bull Cancer; 2001 Aug; 88 Spec No():S14-9. PubMed ID: 11567909
[TBL] [Abstract][Full Text] [Related]
14. [Platinum derivatives].
Sasaki Y
Nihon Rinsho; 2004 Dec; 62 Suppl 12():452-5. PubMed ID: 15658361
[No Abstract] [Full Text] [Related]
15. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
[TBL] [Abstract][Full Text] [Related]
16. Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry.
Björn E; Nygren Y; Nguyen TT; Ericson C; Nöjd M; Naredi P
Anal Biochem; 2007 Apr; 363(1):135-42. PubMed ID: 17286953
[TBL] [Abstract][Full Text] [Related]
17. Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin.
Morrison JG; White P; McDougall S; Firth JW; Woolfrey SG; Graham MA; Greenslade D
J Pharm Biomed Anal; 2000 Dec; 24(1):1-10. PubMed ID: 11108533
[TBL] [Abstract][Full Text] [Related]
18. Quantification and clinical application of carboplatin in plasma ultrafiltrate.
Downing K; Jensen BP; Grant S; Strother M; George P
J Pharm Biomed Anal; 2017 May; 138():373-377. PubMed ID: 28260690
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
Holzer AK; Manorek GH; Howell SB
Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
[TBL] [Abstract][Full Text] [Related]
20. The interaction of platinum-based drugs with native biologically relevant proteins.
Brauckmann C; Wehe CA; Kieshauer M; Lanvers-Kaminsky C; Sperling M; Karst U
Anal Bioanal Chem; 2013 Feb; 405(6):1855-64. PubMed ID: 23052861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
